Patents by Inventor Philip R. Andersen

Philip R. Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic device using GP40
    Publication number: 20020095027
    Abstract: A purified polypeptide having an epitope of an antigenic polypeptide of FIV.
    Type: Application
    Filed: September 25, 2001
    Publication date: July 18, 2002
    Inventors: Philip R. Andersen, Thomas P. O'Connor, Quentin J. Tonelli
  • Polypeptides of feline T-cell lymphotropic lentivirus
    Patent number: 6383765
    Abstract: An isolated envelope polypeptide of Feline Immunodeficiency Virus (FIV) that reacts specifically with a gp-130 envelope specific monoclonal antibody. Immunoassays using such isolated polypeptides are also disclosed.
    Type: Grant
    Filed: May 6, 1997
    Date of Patent: May 7, 2002
    Assignee: Idexx Corporation
    Inventors: Philip R. Andersen, Thomas P. O'Connor, Quentin J. Tonelli
  • Polypeptides of feline T-cell lymphotrophic lentivirus
    Patent number: 5656732
    Abstract: Purified polypeptides of Feline Immunodeficiency Virus (FIV) are disclosed. The polypeptides of the invention include p10, p15, p26, gp40, gp100 and gp130.
    Type: Grant
    Filed: September 15, 1994
    Date of Patent: August 12, 1997
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Philip R. Andersen, Thomas P. O'Connor, Quentin J. Tonelli
  • Monoclonal antibodies to feline-T-lymphotropic lentivirus
    Patent number: 5177014
    Abstract: Monoclonal antibodies specific for an epitope of an FIV-encoded antigen.
    Type: Grant
    Filed: December 5, 1989
    Date of Patent: January 5, 1993
    Assignee: Idexx Laboratories, Inc.
    Inventors: Thomas P. O'Connor, Quentin J. Tonelli, Philip R. Andersen